Stryker Corp. (SYK)
353.75
+4.52
(+1.29%)
USD |
NYSE |
Dec 10, 16:00
354.39
+0.64
(+0.18%)
After-Hours: 20:00
Stryker Cash from Investing (Quarterly): -321.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | -163.30M |
| Intuitive Surgical, Inc. | 401.00M |
| Boston Scientific Corp. | -502.00M |
| Abbott Laboratories | -457.00M |
| Globus Medical, Inc. | -75.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.54B |
| Cash from Financing (Quarterly) | -339.00M |
| Free Cash Flow | 4.073B |
| Free Cash Flow Per Share (Quarterly) | 3.499 |
| Free Cash Flow to Equity (Quarterly) | 1.348B |
| Free Cash Flow to Firm (Quarterly) | 1.484B |
| Free Cash Flow Yield | 2.98% |